Searched for
HEALTHSCIENCES
Cipla shares in focus after deal to acquire Inzpera Healthsciences for Rs 111 croreCipla shares: Cipla has agreed to acquire a 100% stake in Inzpera Healthsciences, making it a wholly owned subsidiary, as part of its strat...- Stocks in news: SBI, M&M, Airtel, Adani Enterprises, Power GridIndian markets showed stability, consolidating after October's gains. Corporate earnings and trade developments are now key drivers. Titan ...
- Cipla to fully acquire Inzpera HealthscienceDrug maker Cipla has acquired Inzpera Healthscience for approximately Rs 111 crore. This strategic move combines Inzpera's paediatric produ...
- Regulatory hurdles in US, UK hamper diagnostics outsourcingOutsourcing of diagnostics and lab-testing services to India has proved to be a non-starter as regulatory hurdles in US and UK make it mand...
- Recession not to hit clinical trials: CROsIndian clinical research organisations do not see any near-term impact of recession as large pharma customers such as AstraZeneca and Glaxo...
- Will pharma sector finally take consolidation pill?Buyout attempts of Orchid & Dabur Pharma may activate domestic market which had long been immune to consolidation attempts due to reluctanc...
- Wipro launches service for US Health Plans mktWipro Technologies, the Global IT Services Business of Wipro Ltd, and Health Sciences Institute on Wednesday announced the launch of "Accel...
- Matrix deal to trigger M&As in pharma secGlobal majors, Teva, Watson, Barr and Activis are also eyeing mid-sized and large Indian cos.
- Global pharma cos may pop in buyout pillThe high-profile Mylan-Matrix deal is likely to trigger a series of mergers and acquisitions (M&A) in the Indian pharmaceutical market. Aro...
Load More- Regulatory hurdles in US, UK hamper diagnostics outsourcing
